COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 2302: Articles 23011-23020  | Next

Improved estimation of time-varying reproduction numbers at low case incidence and between epidemic waves
Parag, K. V.
10.1101/2020.09.14.20194589 — Posted: 2020-09-18
COVID-19 epidemic severity is associated with timing of non-pharmaceutical interventions
Ragonnet-Cronin, M., Boyd, O., Geidelberg, L., Jorgensen, D., Nascimento, F. F., Siveroni, I., Johnson, R., Baguelin, M., Cucunuba, Z. M., Jauneikaite, E., Mishra, S., Thompson, H. A., Watson, O. J., Ferguson, N., Donnelly, C. A., Volz, E.
10.1101/2020.09.15.20194258 — Posted: 2020-09-18
Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers
Wang, T., Smith, D. A., Campbell, C., Harris, S., Salih, H., Varnai, K. A., Woods, K., Noble, T., Freeman, O., Moysova, Z., Marjot, T., Webb, G. J., Davies, J., Barnes, E., Matthews, P. C.
10.1101/2020.09.15.20194985 — Posted: 2020-09-18
Distribution equality as an optimal epidemic mitigation strategy
Hacohen, A., Cohen, R., Efroni, S., Bachelet, I., Barzel, B.
10.1101/2020.09.15.20194506 — Posted: 2020-09-18
An Application of Logistic Formula to Deaths by COVID-19 in Japan
Saito, T.
10.1101/2020.09.15.20195081 — Posted: 2020-09-18
What Does the Public Want to Know About The COVID-19 Pandemic? A Systematic Analysis of Questions Asked in The Internet
George, J., Gautham, D., Kesarwani, V., Sugumar, P. A., Malhotra, R.
10.1101/2020.09.15.20192039 — Posted: 2020-09-18
Disease control as an optimization problem
Navascues, M., Guryanova, Y., Budroni, C.
10.1101/2020.09.15.20194811 — Posted: 2020-09-18
Acute, non-COVID related medical admissions during the first wave of COVID-19: A retrospective comparison of changing patterns of disease
Riley, B., Packer, M., Gallier, S., Sapey, E., Atkin, C.
10.1101/2020.09.15.20194795 — Posted: 2020-09-18
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: Randomized Control Trial in Singapore
Seneviratne, C. J., Balan, P., Ki, K. K. K., Udawatte, N. S., Lai, D., Lin, D. N. H., Venkatachalam, I., Lim Kheng Sit, J., Moi Lin, L., Oon, L., Goh, B. T., Sim Xiang Ying, J.
10.1101/2020.09.14.20186494 — Posted: 2020-09-18 Discussion: Onsite
Pre-existing T cell memory as a risk factor for severe 1 COVID-19 in the elderly
Bacher, P., Rosati, E., Esser, D., Rios Martini, G., Saggau, C., Schiminsky, E., Dargvainiene, J., Schröder, I., Wieters, I., Eberhardt, F., Neb, H., Khodamoradi, Y., Sonntagbauer, M., Vehreschild, M. J., Conrad, C., Tran, F., Rosenstiel, P., Markewitz, R., Wandinger, K.-P., Rybniker, J., Kochanek, M., Leypoldt, F., Cornely, O. A., Koehler, P., Franke, A., Scheffold, A.
10.1101/2020.09.15.20188896 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).